131 related articles for article (PubMed ID: 7700537)
1. Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy.
Kayser V; Lee SH; Guilbaud G
Neuroscience; 1995 Jan; 64(2):537-45. PubMed ID: 7700537
[TBL] [Abstract][Full Text] [Related]
2. Further evidence for a peripheral component in the enhanced antinociceptive effect of systemic morphine in mononeuropathic rats: involvement of kappa-, but not delta-opioid receptors.
Catheline G; Kayser V; Guilbaud G
Eur J Pharmacol; 1996 Nov; 315(2):135-43. PubMed ID: 8960876
[TBL] [Abstract][Full Text] [Related]
3. Behavioural evidence that systemic morphine may modulate a phasic pain-related behaviour in a rat model of peripheral mononeuropathy.
Attal N; Chen YL; Kayser V; Guilbaud G
Pain; 1991 Oct; 47(1):65-70. PubMed ID: 1663227
[TBL] [Abstract][Full Text] [Related]
4. Prevention of tolerance to the antinociceptive effects of systemic morphine by a selective cholecystokinin-B receptor antagonist in a rat model of peripheral neuropathy.
Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
J Pharmacol Exp Ther; 1997 Sep; 282(3):1366-72. PubMed ID: 9316848
[TBL] [Abstract][Full Text] [Related]
5. Differential behavioral effects of peripheral and systemic morphine and naloxone in a rat model of repeated acute inflammation.
Perrot S; Guilbaud G; Kayser V
Anesthesiology; 2001 May; 94(5):870-5. PubMed ID: 11388540
[TBL] [Abstract][Full Text] [Related]
6. The bidirectional dose-dependent effect of systemic naloxone is also related to the intensity and duration of pain-related disorders: a study in a rat model of peripheral mononeuropathy.
Attal N; Kayser V; Guilbaud G
Brain Res; 1990 Aug; 525(1):170-4. PubMed ID: 2173962
[TBL] [Abstract][Full Text] [Related]
7. In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics.
Idänpään-Heikkilä JJ; Perrot S; Guilbaud G; Kayser V
Eur J Pharmacol; 1997 May; 325(2-3):155-64. PubMed ID: 9163562
[TBL] [Abstract][Full Text] [Related]
8. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats.
Martinez V; Christensen D; Kayser V
Pain; 2002 Oct; 99(3):537-545. PubMed ID: 12406530
[TBL] [Abstract][Full Text] [Related]
9. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
10. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat.
Yamamoto T; Sakashita Y
Anesthesiology; 1999 May; 90(5):1382-91. PubMed ID: 10319787
[TBL] [Abstract][Full Text] [Related]
12. Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats.
Catheline G; Guilbaud G; Kayser V
Eur J Pharmacol; 1998 Sep; 357(2-3):171-8. PubMed ID: 9797033
[TBL] [Abstract][Full Text] [Related]
13. The 'tonic' pain-related behaviour seen in mononeuropathic rats is modulated by morphine and naloxone.
Jazat F; Guilbaud G
Pain; 1991 Jan; 44(1):97-102. PubMed ID: 2038495
[TBL] [Abstract][Full Text] [Related]
14. Differential action of morphine and various opioid agonists on thermal allodynia and hyperalgesia in mononeuropathic rats.
Lee SH; Kayser V; Desmeules J; Guilbaud G
Pain; 1994 May; 57(2):233-240. PubMed ID: 8090518
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive effect of systemic kelatorphan, in mononeuropathic rats, involves different opioid receptor types.
Lee SH; Kayser V; Guilbaud G
Eur J Pharmacol; 1994 Oct; 264(1):61-7. PubMed ID: 7828644
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive effect of (S)-N-desmethyl trimebutine against a mechanical stimulus in a rat model of peripheral neuropathy.
Kayser V; Christensen D; Guilbaud G; Roman F
Life Sci; 2000; 66(5):433-9. PubMed ID: 10670831
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats.
Kayser V; Guilbaud G
Pain; 1990 Jun; 41(3):353-363. PubMed ID: 2388772
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent effect of morphine and time-independent effect of MK-801, an NMDA antagonist, on the thermal hyperesthesia induced by unilateral constriction injury to the sciatic nerve in the rat.
Yamamoto T; Shimoyama N; Asano H; Mizuguchi T
Anesthesiology; 1994 Jun; 80(6):1311-9. PubMed ID: 8010478
[TBL] [Abstract][Full Text] [Related]
19. Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats.
Walker J; Catheline G; Guilbaud G; Kayser V
Pain; 1999 Dec; 83(3):509-516. PubMed ID: 10568859
[TBL] [Abstract][Full Text] [Related]
20. Effects of the novel analgesic, cizolirtine, in a rat model of neuropathic pain.
Kayser V; Farré A; Hamon M; Bourgoin S
Pain; 2003 Jul; 104(1-2):169-77. PubMed ID: 12855326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
